Cargando…

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its r...

Descripción completa

Detalles Bibliográficos
Autores principales: Blokker, Britt A., Maijo, Monica, Echeandia, Marta, Galduroz, Mikel, Patterson, Angela M., Ten, Anna, Philo, Mark, Schungel, Rebecca, Gutierrez‐de Juan, Virginia, Halilbasic, Emina, Fuchs, Claudia, Le Gall, Gwenaelle, Milkiewicz, Malgorzata, Milkiewicz, Piotr, Banales, Jesus M., Rushbrook, Simon M., Mato, José M., Trauner, Michael, Müller, Michael, Martínez‐Chantar, María Luz, Varela‐Rey, Marta, Beraza, Naiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492079/
https://www.ncbi.nlm.nih.gov/pubmed/30229970
http://dx.doi.org/10.1002/hep.30275
_version_ 1783415076332503040
author Blokker, Britt A.
Maijo, Monica
Echeandia, Marta
Galduroz, Mikel
Patterson, Angela M.
Ten, Anna
Philo, Mark
Schungel, Rebecca
Gutierrez‐de Juan, Virginia
Halilbasic, Emina
Fuchs, Claudia
Le Gall, Gwenaelle
Milkiewicz, Malgorzata
Milkiewicz, Piotr
Banales, Jesus M.
Rushbrook, Simon M.
Mato, José M.
Trauner, Michael
Müller, Michael
Martínez‐Chantar, María Luz
Varela‐Rey, Marta
Beraza, Naiara
author_facet Blokker, Britt A.
Maijo, Monica
Echeandia, Marta
Galduroz, Mikel
Patterson, Angela M.
Ten, Anna
Philo, Mark
Schungel, Rebecca
Gutierrez‐de Juan, Virginia
Halilbasic, Emina
Fuchs, Claudia
Le Gall, Gwenaelle
Milkiewicz, Malgorzata
Milkiewicz, Piotr
Banales, Jesus M.
Rushbrook, Simon M.
Mato, José M.
Trauner, Michael
Müller, Michael
Martínez‐Chantar, María Luz
Varela‐Rey, Marta
Beraza, Naiara
author_sort Blokker, Britt A.
collection PubMed
description Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its role in cholestatic liver disease. We determined SIRT1 expression in livers from patients with cholestatic disease, in two experimental models of cholestasis, as well as in human and murine liver cells in response to bile acid loading. SIRT1‐overexpressing (SIRT(oe)) and hepatocyte‐specific SIRT1‐KO (knockout) mice (SIRT(hep–/–)) were subjected to bile duct ligation (BDL) and were fed with a 0.1% DDC (3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine) diet to determine the biological relevance of SIRT1 during cholestasis. The effect of NorUDCA (24‐norursodeoxycholic acid) was tested in BDL/SIRT(oe) mice. We found that SIRT1 was highly expressed in livers from cholestatic patients, mice after BDL, and Mdr2 knockout mice (Mdr2(–/–)) animals. The detrimental effects of SIRT1 during cholestasis were validated in vivo and in vitro. SIRT(oe) mice showed exacerbated parenchymal injury whereas SIRT(hep–/–) mice evidenced a moderate improvement after BDL and 0.1% DDC feeding. Likewise, hepatocytes isolated from SIRT(oe) mice showed increased apoptosis in response to bile acids, whereas a significant reduction was observed in SIRT(hep–/–) hepatocytes. Importantly, the decrease, but not complete inhibition, of SIRT1 exerted by norUDCA treatment correlated with pronounced improvement in liver parenchyma in BDL/SIRT(oe) mice. Interestingly, both SIRT1 overexpression and hepatocyte‐specific SIRT1 depletion correlated with inhibition of FXR, whereas modulation of SIRT1 by NorUDCA associated with restored FXR signaling. Conclusion: SIRT1 expression is increased during human and murine cholestasis. Fine‐tuning expression of SIRT1 is essential to protect the liver from cholestatic liver damage.
format Online
Article
Text
id pubmed-6492079
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64920792019-05-06 Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease Blokker, Britt A. Maijo, Monica Echeandia, Marta Galduroz, Mikel Patterson, Angela M. Ten, Anna Philo, Mark Schungel, Rebecca Gutierrez‐de Juan, Virginia Halilbasic, Emina Fuchs, Claudia Le Gall, Gwenaelle Milkiewicz, Malgorzata Milkiewicz, Piotr Banales, Jesus M. Rushbrook, Simon M. Mato, José M. Trauner, Michael Müller, Michael Martínez‐Chantar, María Luz Varela‐Rey, Marta Beraza, Naiara Hepatology Original Articles Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its role in cholestatic liver disease. We determined SIRT1 expression in livers from patients with cholestatic disease, in two experimental models of cholestasis, as well as in human and murine liver cells in response to bile acid loading. SIRT1‐overexpressing (SIRT(oe)) and hepatocyte‐specific SIRT1‐KO (knockout) mice (SIRT(hep–/–)) were subjected to bile duct ligation (BDL) and were fed with a 0.1% DDC (3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine) diet to determine the biological relevance of SIRT1 during cholestasis. The effect of NorUDCA (24‐norursodeoxycholic acid) was tested in BDL/SIRT(oe) mice. We found that SIRT1 was highly expressed in livers from cholestatic patients, mice after BDL, and Mdr2 knockout mice (Mdr2(–/–)) animals. The detrimental effects of SIRT1 during cholestasis were validated in vivo and in vitro. SIRT(oe) mice showed exacerbated parenchymal injury whereas SIRT(hep–/–) mice evidenced a moderate improvement after BDL and 0.1% DDC feeding. Likewise, hepatocytes isolated from SIRT(oe) mice showed increased apoptosis in response to bile acids, whereas a significant reduction was observed in SIRT(hep–/–) hepatocytes. Importantly, the decrease, but not complete inhibition, of SIRT1 exerted by norUDCA treatment correlated with pronounced improvement in liver parenchyma in BDL/SIRT(oe) mice. Interestingly, both SIRT1 overexpression and hepatocyte‐specific SIRT1 depletion correlated with inhibition of FXR, whereas modulation of SIRT1 by NorUDCA associated with restored FXR signaling. Conclusion: SIRT1 expression is increased during human and murine cholestasis. Fine‐tuning expression of SIRT1 is essential to protect the liver from cholestatic liver damage. John Wiley and Sons Inc. 2019-01-29 2019-02 /pmc/articles/PMC6492079/ /pubmed/30229970 http://dx.doi.org/10.1002/hep.30275 Text en © 2018 The Authors Hepatology published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Blokker, Britt A.
Maijo, Monica
Echeandia, Marta
Galduroz, Mikel
Patterson, Angela M.
Ten, Anna
Philo, Mark
Schungel, Rebecca
Gutierrez‐de Juan, Virginia
Halilbasic, Emina
Fuchs, Claudia
Le Gall, Gwenaelle
Milkiewicz, Malgorzata
Milkiewicz, Piotr
Banales, Jesus M.
Rushbrook, Simon M.
Mato, José M.
Trauner, Michael
Müller, Michael
Martínez‐Chantar, María Luz
Varela‐Rey, Marta
Beraza, Naiara
Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title_full Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title_fullStr Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title_full_unstemmed Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title_short Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
title_sort fine‐tuning of sirtuin 1 expression is essential to protect the liver from cholestatic liver disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492079/
https://www.ncbi.nlm.nih.gov/pubmed/30229970
http://dx.doi.org/10.1002/hep.30275
work_keys_str_mv AT blokkerbritta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT maijomonica finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT echeandiamarta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT galdurozmikel finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT pattersonangelam finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT tenanna finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT philomark finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT schungelrebecca finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT gutierrezdejuanvirginia finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT halilbasicemina finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT fuchsclaudia finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT legallgwenaelle finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT milkiewiczmalgorzata finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT milkiewiczpiotr finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT banalesjesusm finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT rushbrooksimonm finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT matojosem finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT traunermichael finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT mullermichael finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT martinezchantarmarialuz finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT varelareymarta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease
AT berazanaiara finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease